API | diphemanil methylsulfate

diphemanil methylsulfate (prantal) Report issue

Small molecule Approved ^FDA

ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem

Active Ingredient History

NOW

Now

Diphemanil methylsulfate (Prantal), a quarternary amine, is a highly specific parasympathetic blocking agent. ^NCATS

Chemistry

SMILES: C[N+]1(C)CCC(=C(c2ccccc2)c3ccccc3)CC1
InChIKey: LCTZPQRFOZKZNK-UHFFFAOYSA-N
Mol. Mass: 278.42
ALogP: 4.36 Partition coefficient
ChEMBL Molecules:

diphemanil

diphemanil methylsulfate

More Chemistry

Pharmacology

Mechanisms of Action:
- Muscarinic acetylcholine receptor M1 (Homo sapiens) ^UniProt
- Muscarinic acetylcholine receptor M3 (Homo sapiens) ^UniProt
Multi-specific: Missing data
Black Box: No
Availability: Discontinued
Delivery Methods: Oral
Pro Drug: No

4-(diphenylmethylene)-1,1-dimethylpiperidinium methyl sulfate | biphemanil | diphemanil | diphemanili metilsulfas | diphemanil methosulfate | diphemanil methylsulfat | diphemanil methylsulfate | diphemanil methyl sulfate | diphemanil metilsulfate | diphenmanil methylsulfate | diphenmethanil | diphenmethanil methylsulfate | métilsulfate de diphémanil | metilsulfato de difemanilo | n,n-dimethyl-4-piperidylidene-1,1-diphenylmethane methylsulfate | p-(alpha-phenylbenzylidene)-1,1-dimethylpiperidinium methyl sulfate | prantal | vagophemanil

Organizations (2)

Research & Development (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (2)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (4)

Approved Indications (4)

Experimental Indications - Clinical Trial Phases 1-4 (0)

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue